Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing geriatric population
3.2.1.2 Rising prevalence of targeted diseases
3.2.1.3 Technological advancement in theranostics
3.2.1.4 Growing focus on precision medicine
3.2.2 Industry pitfalls & challenges
3.2.2.1 Limited duration of activity exhibited by radiopharmaceuticals
3.2.2.2 Lack of favourable reimbursement scenario
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Diagnostic imaging
5.2.1 MRI
5.2.2 PET iamging
5.2.3 Nuclear imaging
5.2.4 CT scan
5.2.5 Molecular imaging
5.2.6 Other diagnostic imaging
5.3 Radiopharmaceuticals
5.3.1 Lutetium-177
5.3.2 Samarium-153
5.3.3 Radium-223
5.3.4 Iodine-131
5.3.5 Yttrium-90
5.3.6 Gallium-68
5.3.7 Fluorine-18
5.3.8 Other radiopharmaceuticals
5.4 IVD/Biomarkers screening
5.4.1 Polymerase chain reaction (PCR)
5.4.2 Next-generation sequencing (NGS)
5.4.3 Fluorescence in-situ hybridization (FISH)
5.5 Software and services
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Prostate cancer
6.3 Bone metastasis
6.4 Neuroendocrine tumors
6.5 Lymphoma
6.6 Cardiovascular diseases
6.7 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Diagnostics centers
7.4 Specialty clinics
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.5.3 Mexico
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Bayer AG
9.2 Beckman Coulter, Inc.
9.3 Cardinal Health, Inc.
9.4 Canon Medical Systems Corporation
9.5 Curium
9.6 F. Hoffmann La Roche Ltd.
9.7 GE HealthCare Technologies Inc.
9.8 Koninklijke Philips N.V.
9.9 Lantheus Holdings, Inc.
9.10 Siemens Healthnieers AG
9.11 Thermo Fisher Scientific Inc.
